Cross‑reactivity between Parietaria judaica and Parietaria officinalis in immunotherapy extracts for the treatment of allergy to Parietaria

Cancelliere,Nataly; Iglesias,Irene; Ayuga,Ángel; Miranda,Ernesto   Enrique

doi:10.3892/br.2020.1297

Cross‑reactivity between Parietaria judaica and Parietaria officinalis in immunotherapy extracts for the treatment of allergy to Parietaria

Authors:
- Nataly Cancelliere
- Irene Iglesias
- Ángel Ayuga
- Ernesto Enrique Miranda
View Affiliations

Affiliations: Medical Department, MERCK SLU, 28006 Madrid, Spain, Department of Allergology, Hospital of Sagunto, 46520 Valencia, Spain
Published online on: April 6, 2020 https://doi.org/10.3892/br.2020.1297
Pages: 326-332

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Parietaria judaica and P. officinalis are the two most common subspecies of the Parietaria genus. P. judaica and P. officinalis have exhibited cross‑reactivity in previous studies. P. judaica pollen is the main cause of allergy in the Mediterranean area. It has been shown that a high percentage of patients sensitized to P. judaica with allergic rhinitis (AR) have an increased risk of developing asthma. The present study aimed to confirm the cross‑reactivity between P. judaica and P. officinalis and to evaluate the use of a single P. officinalis extract in patients allergic to both subspecies as a preferable option for the diagnosis and treatment of allergy in a highly pollinated area of the Spanish Mediterranean coast. The present study was a single centre, observational cross‑sectional study of adult patients diagnosed with AR and/or bronchial asthma who were sensitized to Parietaria pollen. A total of 24 patients were enrolled in the study and included in the analysis. Allergovit® immunotherapy extracts were selected for the study based on the protein content (P. officinalis pollen extract). The results of an in vitro ELISA revealed that 79.1% (n=19) of the patient sera were reactive to immunotherapy extracts. ELISA inhibition assay of the IgE binding to P. officinalis demonstrated inhibition values >70% in the sera of highly reactive patients, confirming the cross‑reactivity between the two Parietaria subspecies. In addition, all patients enrolled in the study exhibited double skin positivity against P. judaica and P. officinalis extracts, as assessed by the skin prick test, further supporting the in vivo reactivity between the two subspecies. The present study demonstrated that P. judaica and P. officinalis pollen extracts were highly cross‑reactive, and that a unique P. officinalis pollen extract may be used for the diagnosis and immunotherapy of patients allergic to Parietaria.

View Figures

View References

1	Bousquet J, Van Cauwenberge P and Khaltaev N: Aria Workshop Group World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 108 (Suppl 5):S147–S334. 2001.PubMed/NCBI View Article : Google Scholar
2	Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 63 (Suppl 86):S8–S160. 2008.PubMed/NCBI View Article : Google Scholar
3	Bauchau V and Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 24:758–764. 2004.PubMed/NCBI View Article : Google Scholar
4	Mullol J, Valero A, Alobid I, Bartra J, Navarro AM, Chivato T, Khaltaev N and Bousquet J: Allergic rhinitis and its impact on asthma update (ARIA 2008). The perspective from Spain. J Investig Allergol Clin Immunol. 18:327–334. 2008.PubMed/NCBI
5	Canonica GW, Bousquet J, Mullol J, Scadding GK and Virchow JC: A survey of the burden of allergic rhinitis in Europe. Allergy. 62 (Suppl 85):S17–S25. 2007.PubMed/NCBI View Article : Google Scholar
6	Bousquet J, Vignola AM and Demoly P: Links between rhinitis and asthma. Allergy. 58:691–706. 2003.PubMed/NCBI View Article : Google Scholar
7	Pereira C, Valero A, Loureiro C, Dávila I, Martinez-Cócera C, Murio C, Rico P and Palomino R: Iberian study of aeroallergens sensitisation in allergic rhinitis. Eur Ann Allergy Clin Immunol. 38:186–194. 2006.PubMed/NCBI
8	Navarro A, Valero A, Julià B and Quirce S: Coexistence of Asthma and Allergic Rhinitis in Adult Patients Attending Allergy Clinics: ONEAIR Study. J Investig Allergol Clin Immunol. 18:233–238. 2008.PubMed/NCBI
9	Leynaert B, Neukirch C, Kony S, Guénégou A, Bousquet J, Aubier M and Neukirch F: Association between asthma and rhinitis according to a topic sensitization in a population-based study. J Allergy Clin Immunol. 113:86–93. 2004.PubMed/NCBI View Article : Google Scholar
10	Kanani AS, Broder I, Greene JM and Tarlo SM: Correlation between nasal symptoms and asthma severity in patients with atopic and nonatopic asthma. Ann Allergy Asthma Immunol. 94:341–347. 2005.PubMed/NCBI View Article : Google Scholar
11	Sala-Cunill A, Bartra J, Dalmau G, Tella R, Botey E, Raga E and Valero A: Comitè de Allergia Respiratòria de Catalunya, Spa in:. Prevalence of asthma and severity of allergic rhinitis comparing 2 perennial allergens: House dust mites and Parietaria judaica pollen. J Investig Allergol Clin Immunol. 23:145–151. 2013.PubMed/NCBI
12	Passalacqua G and Canonica GW: Impact of rhinitis on airway inflammation: Biological and therapeutic implications. Respir Res. 2:320–323. 2001.PubMed/NCBI View Article : Google Scholar
13	de Benedictis FM, del Guidice MM, Severine S and Bonifazi F: Rhinitis, sinusitis and asthma: One linked airway disease. Pediatr Respir Rev. 2:358–364. 2001.PubMed/NCBI View Article : Google Scholar
14	D'Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maessano I, Behrehdt H, Liccardi G, Popov T and van Cauwenberge P: Allergenic pollen and pollen allergy in Europe. Allergy. 62:976–990. 2007.PubMed/NCBI View Article : Google Scholar
15	Ariano R, Cecchi L, Voltolini S, Quercia O, Scopano E and Ciprandi G: AAIITO Study group on Pollen Allergy. Parietaria pollination duration: Myth or fact? Eur Ann Allergy Clin Immunol. 49:6–10. 2017.PubMed/NCBI
16	Colombo P, Duro G, Costa MA, Izzo V, Mirisola M, Locorotondo G, Cocchiara R and Geraci D: An update on allergens Parietaria pollen allergens. Allergy. 53:917–921. 1998.PubMed/NCBI View Article : Google Scholar
17	Polosa R, Al-Delaimy WK, Russo C, Piccillo G and Sarvà M: Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: A retrospective cohort study. Respir Res. 6(153)2005.PubMed/NCBI View Article : Google Scholar
18	Geraci D, Billesbolle KB, Cocchiara R, Løwenstein H and Ipsen H: Immunochemical characterization of antigens of Parietaria judaica pollen. Identification of allergens by means of crossed radio immunoelectrophoresis. Int Arch Allergy Appl Immunol. 78:421–428. 1985.PubMed/NCBI
19	Ford SA, Baldo BA, Geraci D and Bass D: Identification of Parietaria judaica pollen allergens. Int Arch Allergy Appl Immunol. 79:120–126. 1986.PubMed/NCBI View Article : Google Scholar
20	Costa MA, Colombo P, Izzo V, Kennedy H, Venturella S, Cocchiara R, Mistrello G, Falagiani P and Geraci D: cDNA cloning, expression and primary structure of Par jI, a major allergen of Parietaria judaica pollen. FEBS Lett. 341:182–186. 1994.PubMed/NCBI View Article : Google Scholar
21	Duro G, Colombo P, Assunta Costa M, Izzo V, Porcasi R, Di Fiore R, Locorotondo G, Cocchiara R and Geraci D: Isolation and characterization of two cDNA clones coding for isoforms of the Parietaria judaica major allergen Par j 1.0101. Int. Arch. Allergy Appl Immunol. 112:348–355. 1997.PubMed/NCBI View Article : Google Scholar
22	Longo V, Costa MA, Cibella F, Cuttitta G, La Grutta S and Colombo P: Multiple IgE recognition on the major allergen of the Parietaria pollen Par j 2. Mol Immunol. 63:412–419. 2015.PubMed/NCBI View Article : Google Scholar
23	Corbi AL, Pelaez A, Errigo E and Carreira J: Cross-reactivity between Parietaria judaica and Parietaria officinalis. Ann Allergy. 54:142–147. 1985.PubMed/NCBI
24	Dreborg S, Basomba A and Einarsson R: Sensitivity to Parietaria officinalis and Parietaria judaica pollen allergens in a Spanish population. Allergol Immunopathol (Madr). 14:499–508. 1986.PubMed/NCBI
25	Bonura A, Artale A, Marino M, Amoroso S, Marcucci F, Geraci D and Colombo P: Cross-reactivity between Parietaria species using the major rParj1 and rParj2 allergens. Allergy Asthma Proc. 27:378–382. 2006.PubMed/NCBI View Article : Google Scholar
26	Patriarca G, Marino G, De Pasquale T, Broutin O, Viatte A, Jain K, Hrabina M, Gouyon B, Moingeon P, Frati F, et al: Parietaria officinalis pollen extract can replace Parietaria judaica in the diagnosis and immunotherapy of Parietaria allergy. Allergy. 65 (Suppl 92):S209–S682. 2010.
27	Sander I, Fleischer C, Meurer U, Brüning T and Raulf-Heimsoth M: Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy. 64:1486–1492. 2009.PubMed/NCBI View Article : Google Scholar
28	Aalberse RC: Assessment of allergen cross-reactivity. Clin Mol Allergy. 5(2)2007.PubMed/NCBI View Article : Google Scholar
29	Aalberse RC, Akkerdaas J and van Ree R: Cross-reactivity of IgE antibodies to allergens. Allergy. 56:478–490. 2001.PubMed/NCBI View Article : Google Scholar